Literature DB >> 8629305

The liver neither protects the kidney from rejection nor improves kidney graft survival after combined liver and kidney transplantation from the same donor.

S Katznelson1, J M Cecka.   

Abstract

It has been proposed that the liver protects a simultaneously transplanted kidney from acute rejection. Using the United Network for Organ Sharing database, we compared the kidney allograft data from 248 combined liver and kidney transplants (LKT) with a control group comprising 206 contralateral kidney alone transplants (KAT) from the same donor. The LKT and KAT groups were identical with respect to most baseline parameters, save a greater degree of HLA matching in the KAT group. The overall 3-year graft survival rate was higher in the KAT group compared with the LKT group (80% vs 68%, P < 0.01). When these data were censored to remove death as a cause of graft loss and to minimize the matching effect, the 3-year survival rates were not statistically different (78% for KAT and 81% for LKT, P = NS). We conclude that the liver neither protects the kidney from rejection nor improves kidney allograft function or survival after LKT.

Entities:  

Mesh:

Year:  1996        PMID: 8629305     DOI: 10.1097/00007890-199605150-00021

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

1.  Decreased expression of the interleukin 2 receptor on CD8 recipient lymphocytes in intestinal grafts rendered tolerant by liver transplantation in rats.

Authors:  S Sarnacki; H Nakai; D Calise; T Azuma; N Brousse; Y Révillon; N Cerf-Bensussan
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

2.  Recipient survival and graft survival are not diminished by simultaneous liver-kidney transplantation: an analysis of the united network for organ sharing database.

Authors:  Eric F Martin; Jonathan Huang; Qun Xiang; John P Klein; Jasmohan Bajaj; Kia Saeian
Journal:  Liver Transpl       Date:  2012-08       Impact factor: 5.799

3.  Mass cytometry reveals a distinct immunoprofile of operational tolerance in pediatric liver transplantation.

Authors:  Audrey H Lau; Matthew J Vitalone; Kelly Haas; Todd Shawler; Carlos O Esquivel; William E Berquist; Olivia M Martinez; Ricardo O Castillo; Sheri M Krams
Journal:  Pediatr Transplant       Date:  2016-10-26

4.  Factors predicting kidney delayed graft function among recipients of simultaneous liver-kidney transplantation: A single-center experience.

Authors:  Islam M Korayem; Vatche G Agopian; Keri E Lunsford; Hans A Gritsch; Jeffrey L Veale; Gerald S Lipshutz; Hasan Yersiz; Coney L Serrone; Fady M Kaldas; Douglas G Farmer; Suphamai Bunnapradist; Gabriel M Danovitch; Ronald W Busuttil; Ali Zarrinpar
Journal:  Clin Transplant       Date:  2019-05-07       Impact factor: 2.863

Review 5.  Protecting the Kidney in Liver Transplant Recipients: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.

Authors:  J Levitsky; J G O'Leary; S Asrani; P Sharma; J Fung; A Wiseman; C U Niemann
Journal:  Am J Transplant       Date:  2016-04-22       Impact factor: 8.086

Review 6.  Management of immunosuppressant agents following liver transplantation: Less is more.

Authors:  Mustafa S Ascha; Mona L Ascha; Ibrahim A Hanouneh
Journal:  World J Hepatol       Date:  2016-01-28

7.  Peripheral phenotype and gene expression profiles of combined liver-kidney transplant patients.

Authors:  Erwan Dumontet; Richard Danger; Parsia A Vagefi; Maria-Carlota Londoño; Annaïck Pallier; Juan José Lozano; Magali Giral; Nicolas Degauque; Jean-Paul Soulillou; Marc Martínez-Llordella; Herman Lee; Marianne Latournerie; Karim Boudjema; Joelle Dulong; Karin Tarte; Alberto Sanchez-Fueyo; Sandy Feng; Sophie Brouard; Sophie Conchon
Journal:  Liver Int       Date:  2015-08-08       Impact factor: 5.828

Review 8.  Liver transplant tolerance and its application to the clinic: can we exploit the high dose effect?

Authors:  Eithne C Cunningham; Alexandra F Sharland; G Alex Bishop
Journal:  Clin Dev Immunol       Date:  2013-11-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.